INmune Bio, Inc.

NASDAQ:INMB

Biotechnology

Healthcare
$1.89 +8.38%

+$0.15 today

Market cap
$50.25M
Beta
0.98
P/E (TTM)
-1.1
EPS (TTM)
-$1.56
52W Low $1.09High $3.24

Volume 0.09M

Average 0.68M

Price history

INmune Bio, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+26.85%

Period high

$2.51

Period low

$1.12

Latest

$1.89

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Sep 23, 2026Sep 23, 2026
3Sep 23, 2026Sep 23, 2026
4Sep 17, 2026Sep 17, 2026
3Sep 16, 2026Sep 16, 2026
8-KSep 14, 2026Sep 14, 2026
10-QAug 6, 2026Aug 6, 2026
8-KJul 31, 2026Jul 31, 2026
4Jul 7, 2026Jul 7, 2026
4Jul 7, 2026Jul 7, 2026
4Jul 7, 2026Jul 7, 2026
8-KJul 1, 2026Jul 1, 2026
8-KJun 23, 2026Jun 23, 2026
8-KJun 17, 2026Jun 17, 2026
8-KJun 2, 2026Jun 2, 2026
8-KMay 14, 2026May 14, 2026

Competitors

Who does INmune Bio, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about INMB's filings, answered from its disclosures.

What is the latest INMB filing?

The latest filing shown is 3 dated Sep 23, 2026.

How many recent filings does INMB have?

Intrinsic Alpha currently shows 20 recent filings for INMB.